implant available Articles
-
Corey’s Story: First Patient Treated with BEAR® Implant Going Strong After Six Years
Before any new medical technology is approved for use by the U.S. Food and Drug Administration, a considerable number of courageous patients must first agree to participate in clinical trials of the new technology – without any data on potential success rates. For the BEAR® Implant, that brave patient was Corey Peak, a recreational athlete who tore his anterior cruciate ligament (ACL) ...
-
Heal Your Torn ACL with the BEAR Implant
The anterior cruciate ligament, better known as the ACL, is one of the four ligaments within the knee that connect the femur to the tibia. It’s also one of the most commonly injured ligaments in the knee, especially among athletes. Unlike many other ligaments in the body, the ACL does not have the ability to heal on its own. A thick liquid – called synovial fluid – reduces ...
-
Part 1: In-vitro release of gentamicinpalmitate coating in uncemented titanium implants
Microporous surfaces of commercially available uncemented Tilastan® implants were coated with gentamicinpalmitate. The roughness of the titanium implant surfaces remained largely intact. During the first few days, the gentamicin release was comparable to the elution of this antibiotic from commercially available PMMA bone cements. Compared to PMMA cements, the implants coated with the ...
-
CMS Grants Transitional Pass-Through (TPT) Payment for Carlsmed`s aprevo® Personalized Interbody Devices
CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed announced today that the Center for Medicare & Medicaid Services (CMS) has granted aprevo® a Transitional Pass-Through (TPT) payment as part of the quarterly update of the 2021 Medicare Hospital Outpatient Prospective Payment System. The aprevo® Personalized Interbody Devices were the only devices to receive TPT status in this update. The ...
-
Platform technologies to support brain-computer interfaces
There is a lack of adequate and cost-effective treatment options for many neurodegenerative diseases. The number of affected patients is in the millions, and this number will only increase as the population ages. The developing areas of neuromimetics and stimulative implants provide hope for treatment, as evidenced by the currently available, but limited, implants. New technologies are emerging ...
-
Long-Term Outcomes Following Lumbar Nucleus Replacement
Abstract Background Nucleus replacement devices are designed to replace the native pain-generating lumbar nucleus while preserving the annulus fibrosus, endplates, and natural motion. The DASCOR Disc Arthroplasty Device seemed to perform well clinically but was discontinued in 2009. While there are no commercially available NRDs today, the potential advantages of using such devices have ...
-
Remote Oncology Care: Review of Current Technology and Future Directions
Abstract Cancer patients frequently develop tumor and treatment-related complications, leading to diminished quality of life, shortened survival, and overutilization of emergency department and hospital services. Outpatient oncology treatment has potential to leave cancer patients unmonitored for long periods while at risk of clinical deterioration which has been exaggerated during the COVID19 ...
By Oncodisc
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you